Evidence map›Paper›PMID 39264110›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2024

Neighborhood Disadvantage and Prostate Tumor Aggressiveness among African American and European American Men.

Joseph Boyle, Jessica Yau, Jimmie L Slade, Derrick A Butts, Jessica Wimbush, Jong Y Park, Arif Hussain, Eberechukwu Onukwugha, Cheryl L Knott, David C Wheeler and 1 more

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Cancer statistics, 2025.CA: a cancer journal for clinicians
    Article
  4. Cancer statistics, 2026.CA: a cancer journal for clinicians
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Joseph BoyleDepartment of Biostatistics, Virginia Commonwealth University, Richmond, Virginia.ORCID 0000-0002-1411-5584
Jessica YauDepartment of Cellular and Molecular Biomedical Science, University of Maryland School of Medicine, Baltimore, Maryland.ORCID 0000-0001-6722-6686
Jimmie L SladeCommunity Ministry of Prince George's County, Upper Marlboro, Maryland.ORCID 0000-0002-4421-9691
Derrick A ButtsProstate Health Matters, Washington, District of Columbia.ORCID 0009-0004-8172-2247
Jessica WimbushUniversity of Maryland Greenebaum Comprehensive Cancer Center Tumor Registry, Baltimore, Maryland.ORCID 0009-0003-8774-6971
Jong Y ParkDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center, Tampa, Florida.ORCID 0000-0002-6384-6447
Arif HussainDepartment of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.ORCID 0000-0001-8485-4406
Eberechukwu OnukwughaProgram in Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland.ORCID 0000-0001-8547-1810
Cheryl L KnottProgram in Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland.ORCID 0000-0002-2261-7875
David C WheelerDepartment of Biostatistics, Virginia Commonwealth University, Richmond, Virginia.ORCID 0000-0001-8121-5182
Kathryn Hughes BarryProgram in Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland.ORCID 0000-0003-4661-0595

Funding

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FEYRUZ VIRGILIA RASSOOL · 2008 to 2026
$51.0M
Training Program in Cancer Prevention and Control and Cancer Health Equity (CPC-CHE)T32CA093423 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Bernard F Fuemmeler, Oxana G Palesh · 2018 to 2026
$3.0M
Epigenomic and transcriptomic markers of aggressive prostate cancer among African American menK07CA230182 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI BARRY, KATHRYN HUGHES · 2018 to 2023
$827k
American Cancer Society (ACS) IRG-18-160-16Maryland Department of Health (DHMH) CH-649-CRFNational Cancer Institute (NCI) K07CA230182National Cancer Institute (NCI) P30CA134274NCI NIH HHS K07 CA230182NCI NIH HHS P30 CA134274NCI NIH HHS T32 CA093423
6 · The paper itself

Abstract

backgroundStudies have identified associations between neighborhood disadvantage (ND), which is more likely to affect African American (AA) individuals, and aggressive prostate cancer. Thus, ND may contribute to prostate cancer disparities. However, it is unknown what ND components drive aggressive disease and whether associations vary by race.

methodsWe evaluated associations between aggressive prostate cancer and four ND metrics-Area Deprivation Index (ADI), validated Bayesian Neighborhood Deprivation Index (NDI), racial isolation (RI) index, and historical redlining, and whether these factors interacted with race, among men with prostate cancer treated at the University of Maryland Greenebaum Comprehensive Cancer Center (2004-2021).

resultsWe included 1,458 men (698 European American and 760 AA). AA men were more likely to experience ND. In adjusted models, the ADI, RI, and redlining were significantly associated with aggressive versus nonaggressive prostate cancer overall [ADI, OR for one SD increase = 1.14, 95% confidence interval (CI), 1.00-1.30; RI, OR = 1.27, CI, 1.07-1.51; redlining, OR = 1.77; CI, 1.23-2.56] and among AA men. The NDI was associated with aggressive prostate cancer among AA men (OR = 1.32, 95% credible interval: 1.13-1.57); percent in poverty received the largest importance weight. The ADI (P heterogeneity = 0.002) and NDI (exceedance probability heterogeneity = 98.1%) significantly interacted with race, such that associations were significantly stronger for AA men.

conclusionsWe identified novel significant positive associations for racial segregation and historical redlining with aggressive prostate cancer and significant interactions between ND indices and race. IMPACT: Findings inform specific ND components that are associated with aggressive prostate cancer and suggest the ND effect is stronger for AA men, which has implications for interventions to reduce disparities.

Indexed as

Black or African AmericanProstatic NeoplasmsWhiteAgedHumansMaleMarylandMiddle AgedNeighborhood Characteristics

Identifiers

PMID39264110
PMCPMC11614192

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.